|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, April 27, 2017 ) Rising aged population, technological advancement in bio-implants, high level of healthcare awareness and rising disposable incomes are the factors driving the non-surgical bio-implants market. However, high treatment cost, increasing application areas mostly medical and aesthetic for biomaterials used in non-surgical bio-implants and reimbursement issues are the factors hindering the market.
For more information @ http://www.reportsweb.com/non-surgical-bio-implants-global-market-outlook-2015-2022
Collagen based bio-implants holds major share owing to its lower cost and easy availability. North America region has the major market for non-surgical bio-implants in terms of revenue owing to huge number of key players and strong healthcare infrastructure. Europe region is the second leading non-surgical bio-implants market due to technical advancements in the region.
Some of the key players in the market include Novatex Bioengineering SA, LCA Pharmaceuticals, Moma Therapeutics, Inc., Johnson & Johnson, Kythera Pharmaceuticals, Inc., Anika Therapeutics, Inc., Fidia Farmaceutici, FibroGen, Inc., Hangzhou Gallop Biological Products Co. Ltd., Albiorex International BioPolymer GmbH & Co. KG, Adoderm, Nordic Aesthetics, Teoxane Laboratoires and Coapt Systems.
Bio-implants Type Covered:
- Injectable biomaterials
- Hyaluronan
- Hydrogels
- Hyaluronic acid
- Collagen
- Calcium phosphate ceramic pastes
- Biopolymers
- Hydroxyapatite
- Alloplastic biomaterials
- Acrylic hydrogel
- Non-surgical bio-implants
- Viscoaugmentation bio-implants
- Viscosupplementation bio-implants
.
Request Sample Copy dhttp://www.reportsweb.com/inquiry&RW0001216341/sample
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
8 Company Profiling
8.1 Novatex Bioengineering SA
8.2 LCA Pharmaceuticals
8.3 Moma Therapeutics, Inc.
8.4 Johnson & Johnson
8.5 Kythera Pharmaceuticals, Inc.
8.6 Anika Therapeutics, Inc.
8.7 Fidia Farmaceutici
8.8 FibroGen, Inc.
8.9 Hangzhou Gallop Biological Products Co. Ltd.
8.10 Albiorex International
8.11 BioPolymer GmbH & Co. KG
8.12 Adoderm
8.13 Nordic Aesthetics
8.14 Teoxane Laboratoires
8.15 Coapt Systems
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216341/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
